Our purpose and ambition: GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance. We are a company where outstanding people can thrive. In China, we have always been dedicated to helping to transform the health, lives, and future of Chinese people. GSK in China: • Operate in more than 250 cities and regions in China • Five regional hubs: Beijing, Shanghai, Chengdu, Guangzhou, Hangzhou • 1 GSK Enterprise Management Company in Shanghai • 1 R&D centre in Shanghai • 1 infectious disease and public health institute in Beijing How we're getting ahead in China? • Vaccines: In China, we are one of the leading vaccines suppliers and we are dedicated to making our vaccines available and accessible for people in China. Our vaccines for people help to prevent disease, including Shingles, HPV and Hepatitis B. • Medicines: We have a broad portfolio of innovative and established medicines. In China, we focus on the following therapeutic areas: respiratory, hepatitis, neurological disorders, HIV, immunology such as systemic lupus erythematosus, and rare diseases such as pulmonary arterial hypertension and EGPA.